Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:16 PM
Ignite Modification Date: 2025-12-25 @ 8:54 PM
NCT ID: NCT00286156
Description: None
Frequency Threshold: 0
Time Frame: None
Study: NCT00286156
Study Brief: Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Standard Rapamycin Dose (STD) Arm 1 Rapamune dose 2-6mg aimed at maintaining trough levels 5-8 ng/ml Rapamycin: Group 1- doses of Rapamune aimed at maintaining trough levels 5-8ng/ml None None 2 10 10 10 View
Low Dose Rapamycin (LD) Arm 2 Rapamune dose 2-6 mg aimed at maintaining trough levels of 2-5ng/ml Rapamycin: Group 2 - doses of Rapamune aimed at maintaining trough levels 2-5ng/ml None None 1 10 6 10 View
Standard Care Standard Care: fluid intake primarily water of 2500-3000ml/24hrs, low sodium diet of 2300mg/24 hrs, caffeine avoidance, control of hypertension None None 1 10 8 10 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
pulmonary embolus None Respiratory, thoracic and mediastinal disorders None View
nephrotic range proteinuria None Renal and urinary disorders None View
Decrease visual acuity None Eye disorders None View
Hypoglycemia None Metabolism and nutrition disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Oral ulcerations None Immune system disorders None View
Nonserious infections None Infections and infestations None View
Edema None Blood and lymphatic system disorders None View
Gastrointestinal symptoms None Gastrointestinal disorders None View
Dermatitis None Skin and subcutaneous tissue disorders None View
Miscellaneous/other None General disorders None View